Over the past decades, the prognostic role of serum galectin-3 as a biomarker linking oxidative stress, inflammation and fibrosis has been demonstrated in many pathological conditions such as HF, atherosclerosis, CKD and cancer5,20–22. This evidence concerns the gene LGALS3 and atherosclerosis.